Dietary soy isoflavone‐induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo
- 27 July 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 19 (12) , 1755-1757
- https://doi.org/10.1096/fj.05-4008fje
Abstract
Epidemiological evidence suggests that populations consuming large amounts of soy protein have a reduced incidence of coronary heart disease (1-5). The cardiovascular risks associated with conventional hormone replacement therapy in postmenopausal women (5-7) have precipitated a search for alternative estrogen receptor modulators. Here we report that long-term feeding of rats with a soy protein-rich (SP) diet during gestation and adult life results in decreased oxidative stress, improved endothelial function, and reduced blood pressure in vivo measured by radiotelemetry in aged male offspring. Improved vascular reactivity in animals fed an SP diet was paralleled by increased mitochondrial glutathione and mRNA levels for endothelial nitric oxide synthase (eNOS) and the antioxidant enzymes manganese superoxide dismutase and cytochrome c oxidase. Reduced eNOS and antioxidant gene expression, impaired endothelial function, and elevated blood pressure in animals fed a soy-deficient diet was reversed after refeeding them an SP diet for 6 months. Our findings suggest that an SP diet increases eNOS and antioxidant gene expression in the vasculature and other tissues, resulting in reduced oxidative stress and increased NO bioavailability. The improvement in endothelial function, increased gene expression, and reduced blood pressure by soy isoflavones have implications for alternative therapy for postmenopausal women and patients at risk of coronary heart disease.Keywords
Funding Information
- Medical Research Council
- Wellcome Trust
This publication has 51 references indexed in Scilit:
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Isoflavones: their effects on cardiovascular risk and functionsCurrent Opinion in Lipidology, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Soy, Soy Phytoestrogens and Cardiovascular DiseaseJournal of Nutrition, 2002
- Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzeinPublished by Oxford University Press (OUP) ,2000
- Phytoestrogens and cardiovascular healthJournal of the American College of Cardiology, 2000
- Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor βEndocrinology, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Meta-Analysis of the Effects of Soy Protein Intake on Serum LipidsNew England Journal of Medicine, 1995